Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy
Author:
Affiliation:
1. Department of Gynaecology Cangzhou People's Hospital Affiliated to Cangzhou Medical College Cangzhou China
Publisher
Wiley
Subject
Molecular Biology,Structural Biology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmr.2891
Reference47 articles.
1. Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
2. PARP inhibitors in ovarian cancer
3. First‐line PARP inhibition in ovarian cancer ‐ standard of care for all?;Banerjee SN;Nat Rev Clin Oncol,2020
4. Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer
Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer
5. Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin;Hanzlikova H;Nucleic Acids Res,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of the efficacy of marine natural products against PARP-1/2 proteins in high-grade serous ovarian cancer: insights into MD and SMD simulations;Journal of Biomolecular Structure and Dynamics;2024-06-17
2. Latent space feature representation on multiple biological network for synthetic lethality interaction prediction;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05
3. An Efficient Synthesis of PARP Inhibitors Containing a 4-Trifluoromethyl Substituted 3,6,7,7a-Tetrahydro- 1H-pyrrolo[3,4-d]pyrimidine-2,5-dione Scaffold;Journal of Organic and Pharmaceutical Chemistry;2023-11-26
4. An overview of compound properties, multiparameter optimization, and computational drug design methods for PARP-1 inhibitor drugs;European Journal of Medicinal Chemistry;2023-04
5. A systematic review on hyperspectral imaging technology with a machine and deep learning methodology for agricultural applications;Ecological Informatics;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3